TP53 and non-small cell lung carcinoma: To further confirm the substantiality of the immunomodulatory potential of Snail-p53 binding disruption, we examined the top 20 upregulated and downregulated genes, for overlap with the differential immune expression profile of GN25 treated NSCLC cells.